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Abstract
Background: Most laboratory parameters change during pregnancy. A  serial study of a large number of routine 
haematological and biochemical blood parameters and biochemical urine parameters was conducted in a group of 66 
healthy nulliparous pregnant women, who had an uncomplicated pregnancy.
Methods: Blood samples and 24-h urine samples were obtained at four weeks intervals during pregnancy and at 1 
(IP) and 6 (6P) weeks after delivery.
Results: During pregnancy, haemoglobin concentration, haematocrit and erythrocyte count were lower, mean cell 
volume was not different, and mean cell haemoglobin and mean cell haemoglobin concentration were enhanced. The 
platelet count during pregnancy was not different from the level at 6P but increased 60% at IP. Serum ferritin 
decreased 50% whereas plasma fibrinogen increased 100%, Serum creatinine (-28% ), uric acid ( — 35%) and urea 
( — 40%) concentrations were reduced during pregnancy. The serum concentrations of sodium ( - 4  mmol/1) and 
potassium ( - 0 , 2  mmol/1) were lower, but serum chloride was unaltered. Serum protein and albumen concentrations 
declined by 7.8 and 9,4 g/1 respectively. The serum concentrations of bilirubin, ALAT, ASAT and y-GT remained 
unaltered. Scrum LDH was 30% above normal non-pregnant values at IP. The heat-stable alkaline phosphatase 
level increased in the third trimester. Heat-stable and heat-labile fractions were both elevated at IP. The serum 
osmolality was 9 mosmol/kg lower and urine volume was about 25% higher during pregnancy. The creatinine 
excretion was unaltered but creatinine clearance increased by 25%.
Conclusions: The concentrations of most components change during pregnancy. The interpretation of results of 
laboratory tests in pregnant women should be made with caution.
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1. Introduction
Successful outcome of pregnancy requires a 
large number of rather dramatic physiological 
adaptations. These adaptations involve changes 
of the metabolism in most organ systems, result­
ing in changes in the biochemical composition of 
the blood. In order to be able to interpret labora­
tory parameters of pregnant women, physicians 
(next to obstetricians) caring for those women 
have to be aware of these physiological changes 
that accompany normal pregnancy. In the litera­
ture, little attention has been paid to the gesta­
tional changes in electrolytes and other biochemi­
cal components of the serum and haematological 
parameters of the blood in normal human preg­
nancy. Moreover, the scarce literature available is 
inconclusive for several reasons; many studies 
were cross-sectional, the populations studied in­
cluded both nulliparous and multiparous women, 
and pregnancies complicated by pathological con­
ditions were not excluded.
In a longitudinal study we simultaneously stud­
ied a large number of haematological and bio­
chemical blood parameters and the urinary excre­
tion of electrolytes and creatinine. As adaptation 
to pregnancy might change with increasing parity 
[1] and may well be different in abnormal preg­
nancy, our study population was limited to healthy 
nulliparous pregnant women delivering at term a 
healthy and appropriate-for-gestational-age in­
fant after an uncomplicated pregnancy. The re­
sults of the present study are compared with the 
available longitudinal studies.
2. Materials and methods
Study population
The study protocol was approved by the local 
ethics committee of the University Hospital. 
Ninety-eight healthy nulliparous pregnant women 
were included in the study after informed consent 
had been obtained. All pregnancies were single­
ton and accurately dated by the last menstrual 
period, pregnancy test and one or two ultrasound 
investigations before the 12th gestational week. 
After the last check-up at 6 weeks after delivery,
Table 1
Criteria for uncomplicated singleton pregnancy
Delivery > day 259 and < day 294 of gestation 
Birth weight > 10th centilc and < 90th centile 
Biood pressure < 90 mmHg throughout pregnancy 
No proteinuria ( < 300 m g/24 h)
No dietary restrictions in pregnancy
No medication except for iron and vitamin supplements
each pregnancy was classified as having been 
complicated or uncomplicated. Uncomplicated 
pregnancy was defined according to the criteria 
listed in Table 1. Only the data of the pregnan­
cies classified as uncomplicated were used in this 
analysis. According to those criteria, a total of 32 
women were excluded from evaluation for rea­
sons of developing gestational hypertension 
(according to the criteria of Davey and 
MacGillivray, 1988) [2] (n — 16), low birth weight 
( < 10th percentile, n = 9) [3], high birth weight 
( > 90th percentile, n — 6), premature delivery ( < 
37 weeks, n = 8) or postmature delivery ( > 42 
weeks, n “  1). Thus 66 women could be evaluated 
further. None of the participants has been hospi­
talized for severe morning sickness. The group 
characteristics are summarized in Table 2. Since 
most women in our hospital receive oral iron 
supplements during pregnancy, we decided to 
supplement all women from the 20th week until 
delivery to keep the group homogeneous. Some 
women also used folate supplements. Some data 
from 20 women contributed to three previous 
studies [4-6].
Study protocol
The studies were performed between 13,00 
and 17.00 hours. Each individual patient was seen
Table 2
Group characteristics of 66 women with uncomplicated preg­
nancy
Median (min-~max)
Age (yr) 28.0 (21 .2--35,6)
Duration of pregnancy 279 (259- 293)
(days)
Birth weight (g) 3185 (2630-3915)
Percentile birth weight 40 (10-85)
Vaginal blood loss 400 (150- 1300)
after delivery (ml)
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at approximately the same time of day for each 
visit during pregnancy and after delivery.
After an obstetric check-up, blood pressure 
was measured twice, in the sitting position with 
an automatic device, which uses the oscillometric 
principle (Dinamap). Afterwards, blood samples 
were taken from an antecubital vein, after the 
patient had rested for 20 minutes in the left 
lateral tilt position. Patients were asked to refrain 
from eating, drinking coffee and smoking during 
the last hour before venipuncture. In addition, 
24-h urine samples were collected the day before 
each outpatient clinic visit.
Serial measurements were made in weeks 12, 
16, 20, 24, 28, 32, 36, and 38 of pregnancy and at
1 (IP) and 6 (6P) weeks after delivery. The pa­
rameters concerned, the methods of analysis and 
reference values for non-pregnant women are 
listed in Table 3. The creatinine clearance was 
calculated. To correct for possible incomplete 
collection of 24-h urine samples, the urinary ex­
cretions of the electrolytes are presented both as 
excretion in mmol/24 h and as a ratio of the 
electrolyte and creatinine (mmol/mmol) in the
24-h samples. Furthermore, the electrolyte-free 
water clearance (EFWC) was calculated as fol­
lows:
EFWC
— ^ v o l  ^  [ l  {(^[sodium] ^[potassium])/^[sodium]} ]
Table 3
Laboratory techniques and reference values for non-pregnant women from our laboratory
Compound Material Analytical method Reference value
Haemoglobin (Hb) EDTA blood Cyanide method 13-9 .1  mmol/1
Haematocrit (Ht) EDTA blood derived 0.34-0,46 L / l
Erythrocyte count EDTA blood direct count 3.7-5.2X 10l2/ i
Mean cell volume (MCV) EDTA blood direct measurement 80-96 fL
Mean cell haemoglobin (MCH) EDTA blood derived 1600-2000 amol
Mean cell haemoglobin EDTA blood derived 18.5-22.5 mmol/1
concentration (MCHC)
Thrombocyte count EDTA blood direct count 150-350 X 1 0 7 1
Fibrinogen citrate plasma Clauss 1.6—3.2 g/1
Ferritin serum I EM A (Tandem-E-Fer, Hybritech) 15-350 jit g/1
Creatinine serum Jaffé 50-90 }jlm ol/i
Uric acid serum Uricase/catalase reaction 0.15-0.40 mmol/1
Urea se ru m Urease method 3.0-7.0 mmol/1
Sodium serum Indirect potentiometry 137-144 mmol/1
Potassium serum Indirect potentiometry 3.4-4.6 mmol/1
Chloride se ru m Indirect potentiometry 98-107 mmol/1
Protein serum Biuret 60-80 g/1
Albumen serum Bromocresol green 40-55 g/1
Bilirubin serum Caffeine/sodium-benzoate at 30°C < 10 /Ltmol/l
ALAT serum L-Alanine and 2-oxoglutarate 
at 30°C [8]
< 30  lU / i
ASAT serum L-Aspartate and 2-oxoglutarate 
at 30°C [9]
< 25 IU/1
LDH serum Pyruvate at 30°C [10] < 330 IU/1
7-GT serum L-y-Glutamyl-3-carboxy-4-nitroanilide
at 30°C [11]
< 35 IU/1
Alkaline phosphatase serum p-Nitrophenylphosphate at 30°C[12] < 120 IU/1
Osmolality serum Freezing point osmometry 280-300 mosmol/kg
Sodium urine Flame photometry
Potassium urine Flame photometry
Chloride urine Chlorocounter
Creatinine urine Jaffé
Osmolality urine Freezing point osmometry
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where Uvo] is the 24-h urine volume, UIsodiumj and
Ujpotassium] are the urinary concentrations of 
sodium and potassium respectively, and S[sodium] is 
the serum sodium concentration [7]. Bilirubin 
concentration, the liver enzyme concentrations 
and ferritin levels were measured in weeks 12, 32, 
IP and 6P.
In the last 23 women of the study population, 
the osmolality of the serum (Sosmo}) and the urine 
(Uosmoi ) was determined. The excretion of solutes 
was calculated by multiplying urine volume with 
the urine osmolality. In addition, the free-water 
clearance (FWC) was calculated according to the 
following equation:
F W C  =  U vol X [1 -  ( U osmol/ S osmol) ]  •
Statistical analysis
Changes in all parameters studied in compari­
son with values at 6 weeks after delivery (6P) 
were tested with the Wilcoxon matched-pairs 
signed rank test. The level of statistical signifi­
cance for each comparison was taken to be 0.10/& 
(k -  number of comparisons). The total maxi­
mum type I error is then 0.10. Due to the interde­
pendence of the values at the subsequent time 
points, the overall type I error is probably nearer 
to 5% than to 10%. The results are presented in 
box and whisker plots. The upper and the lower 
limits of the box display the 75th and 25th cen­
tiles, the line in between is the median, and the 
lower and upper whiskers respectively indicate 
the 5th and 95th centiles of the distribution. 
Values below the 5th centile and above the 95th 
centile are indicated as points outside the 
whiskers.
3. Results
The laboratory parameters in pregnancy were 
compared with control values at 6 weeks after 
delivery in the same group of women. At 6 weeks
after delivery, the values of most parameters were 
within the normal non-pregnant range. The serum 
ferritin concentration at 6P, however, was below 
the normal non-pregnant range.
Haematological data (Fig. 1)
The median Hb, Ht and erythrocyte count 
were lower throughout pregnancy compared with 
the median levels at 6 weeks post partum (6P). A 
nadir was demonstrated in week 28. The maxi­
mum differences in week 28 compared with week 
6P for Hb, Ht and erythrocyte count were -0 .9  
mmol/1 ( —12%), —0.05 1/1 ( — 13%) and — 0.7 X 
1012 cells/1 ( -1 7 % ) respectively. MCV during 
pregnancy did not differ significantly from the 6P 
value. In the course of pregnancy, however, the 
median MCV increased from 90 at week 12 up to 
91-94 between weeks 20 and 38. MCH and 
MCHC were significantly elevated throughout 
pregnancy as compared with the postpartum val­
ues. Within pregnancy, no large changes were 
observed.
The platelet count did not show major changes 
throughout pregnancy and was not different from 
6P, At 1 week after delivery (IP), however, the 
platelet count was significantly higher than at 6P,
with median values of 387 and 259 X 10V l  re­
spectively. The fibrinogen concentration in week
12 of pregnancy was about 10% higher than at 6P 
and throughout pregnancy this difference in­
creased to about 50% in late gestation.
The highest median serum ferritin concentra­
tion was found in week 12 of pregnancy, and it 
declined afterwards by more than 50% during 
pregnancy to levels comparable with that at 6P. 
At IP, the ferritin concentration was somewhat 
higher than at 6P (Table 4).
Serum concentrations o f  creatinine, urea, uric acid, 
electrolytes and proteins (Fig. 2)
Median serum creatinine and urea concentra­
tions were significantly lower throughout preg­
nancy than at 6P: about 28 and 40% on average,
Fig. 1. Box and whisker plots of haematological parameters during pregnancy and puerperium. MCV == mean cell volume;
MCH = mean cell haemoglobin; MCHC = mean cell haemoglobin concentration. The box displays the 75th and 25th centiles and
the median, the whiskers indicate the 5th and 95th centiles. Values below the 5th centile and above the 95th centile are indicated 
as points outside the whiskers.
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respectively. The median uric acid concentration 
in week 12 was 11 mmol/1 ( — 38%) lower than at 
6P. It increased gradually during pregnancy and 
in late gestation it was no longer different from 
the level at 6P.
Median serum sodium concentration was sta­
ble throughout pregnancy at about 138 mmol/1, 
but significantly lower than at 6P (.142 mmol/1). 
The median serum chloride concentration was 
unchanged compared to the level post partum. 
The median serum potassium level during preg­
nancy was slightly, though significantly, lower than 
at 6P ( - 0 .2  mmol/1). Total serum protein and 
albumen concentrations were markedly lower in 
the course of pregnancy than at 6P. The maximal 
difference of total protein was —8 g/1 ( — 12%) in 
weeks 32 and 36, compared with week 6P. The 
lowest median serum albumen concentrations in 
weeks 32 and 36 were about 9 g/1 ( — 21%) lower 
than those determined post partum.
Urinary excretion o f  electrolytes and creatinine
(Fig, 3)
During pregnancy, urinary sodium excretion 
and sodium/creatinine ratios tended to be slightly 
higher compared with 6P, although differences 
reached statistical significance only at weeks 28 
and 36. The median urinary chloride excretion 
and chloride/creatinine ratio were significantly 
elevated (approximately 20%) compared to 6P, 
Median urinary potassium excretion and potas­
sium/creatinine ratios were about 15% higher 
during pregnancy than at 6P. Urinary excretion of 
creatinine during pregnancy did not differ from
6P. Throughout pregnancy, the median creatinine 
clearance was approximately 35% higher than at
6P.
Urine volume, osmolality o f  serum and urine,
EFWC and FWC (Fig. 4)
Uvol during pregnancy was significantly higher 
(about 25%) than at 6P, Sosmo, was significantly 
lower (about 9 mosmol/kg) during pregnancy. 
Similarly, the Uosmo) was also slightly lower during
pregnancy than in the postpartum period. Statis­
tical significance was reached from week 28 
through week 38, Solute excretion levels were 
approximately 100 mosmol/24 h higher than 
those post partum, although there were no statis­
tically significant differences. The FWC did not 
change very much during pregnancy. The EFWC 
was slightly higher during pregnancy, although 
only at week 32 was the difference statistically 
significant.
Serum concentrations o f  bilirubin, A SAT, ALAT} 
y-GT} L D H  and alkaline phosphatase (Table 4) 
Concentrations of bilirubin, ASAT, ALAT and 
y-GT in serum remained within the normal non­
pregnant range throughout pregnancy and puer- 
perium. The serum levels of LDH were slightly 
lower in early gestation than at 6P. However, 
LDH levels were markedly elevated at IP (about 
30%). In week 32, heat-stable alkaline phos­
phatase was about 6 times as high as at 6P and in 
week 12. Both heat-unstable and heat-stable alka­
line phosphatase were significantly elevated at 
IP.
4. Discussion
The present study describes the changes in­
duced by pregnancy on various haematological 
and biochemical variables in a group of healthy 
nulliparous women who, after an uncomplicated 
pregnancy, delivered an healthy baby with a nor­
mal birth weight.
Haematological data
Our findings on Hb, Ht and erythrocyte count 
confirm those of other serial studies in pregnant 
women receiving iron supplements [13,14], The 
changes in Hb and Ht can be explained by the 
well-known changes in plasma volume and red 
cell mass in pregnancy. The plasma volume in­
creases between the 6th and the 30th week of 
pregnancy by about 1250 ml [15]. The increase in
Fig. 2. Box and whisker plots of serum concentrations of creatinine, uric acid, urea, sodium, potassium, chloride, protein and 
albumen during pregnancy and puerperium. Plot symbols are explained in Fig. 1.
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Table 4
Serum concentrations of liver enzymes and ferritin
Week 12 Week 32 IP 6P
Ferritin ((jlg/1) 4ÏT* 13 24 * ’ 17
(6-130) (3-95) (3-94) (3-97)
Total 4 * 4 * 4 * 5 *
Bilirubin (IU/1) (1- 12) (2-9) (2 - 10) (2-70)
ASAT (IU/1) 9 * 9 * * v 11 10
(4-18) (5—21) (5-103) (6-27)
ALAT (IU/1) 9 * 8 * 12 12
(4-30) (2- 22) (5-115) (3-54)
r-G T (IU/1) 7 6 9 * 7
(2-18) (3-20) (5-79) (4-23)
LDH (IU/1) 186 * 194 259 * 192
(138-328) (127-272) (165-39S) (147-279)
Alkaline phosphatase (IU/1) 
Total 42 * 82 * 97 * 63
(17-88) (46-165) (48-249) (20-117)
Unstable 37 * 48 * 70 * 57
(4-74) (20-96) (6-183) (14-104)
Stable 5 32 * 33 * 5
(1-51) (9-80) (7-78) (1-69)
Values are medians (min-max). Statistical significance (Wilcoxon signed rank) in comparison with 6P: * p  < 0.01; * '  p  < 0.05.
red cell mass between weeks 12 and 36 has been 
found to be approximately 280 ml if no supple­
ments are used and around 450 ml if iron and 
folate are supplemented [16]. The discrepancy 
between rate of increase in plasma volume and 
that in red cell mass leads to a physiological 
decrease in Hb, Ht and erythrocyte count in 
mid-pregnancy. In a study without iron supple­
mentation, serum ferritin concentrations at 6 
months after delivery were still significantly lower 
than in the early stage of pregnancy, suggesting 
that pregnancy without iron supplementation 
leads to depletion of the iron stores [17].
The platelet count was stable throughout preg­
nancy, which confirms other studies [18-21], al­
though a small decrease in late pregnancy has 
been reported [22]. On the 7th postpartum day, 
the platelet count was 60% above the late gesta­
tional level. Others have reported similar in­
creases in the first week post partum [23-25]. 
The temporary increase in the platelet count af­
ter delivery must be considered as a compen­
satory increase in platelet production after a pe­
riod of platelet consumption during separation 
and delivery of the placenta. The peak platelet 
count lasts at least two weeks because the life 
span of platelets is about 8-11 days. [26]. The 
higher platelet count may contribute to the in­
creased risk of thromboembolic complications in 
the puerperium.
Probably as a result of increased production in 
the liver, serum fibrinogen was higher during 
pregnancy than after delivery, which confirms 
other studies [23,27]. Both serum total protein 
( -1 2 % ) and serum albumin ( -2 1 % )  concentra­
tions decreased considerably during pregnancy.
Fig. 3. Box and whisker plots of urine sodium excretion, urine sodium/creatinine ratio, urine potassium excretion, urine 
potassium/creatinine ratio, urine chloride excretion, urine chloride/creatine ratio, urine creatinine excretion and creatinine 
clearance during pregnancy and puerperium. Urine sodium/creat =  Urine sodium/creatinine ratio; Urine potassium /creat =  Urine 
potassium/creatinine ratio; Urine chloride/creat =  Urine chloride /creatinine ratio. Plot symbols are explained in Fig. 1.
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The decrease in the serum albumin explains the 
major portion of the decrease in total protein 
[28].
Serum concentrations of electrolytes
The drop in serum sodium concentration of 4 
mmol/I that was observed is in good agreement 
with the data of other longitudinal studies [29-31].
Serum potassium levels decreased slightly during 
pregnancy. The decrease in serum potassium has 
been reported previously [29], although others did 
not observe a change during pregnancy [31]. 
Serum chloride concentration was unaltered in 
pregnancy. Newman [29] observed a minor de­
crease in the serum chloride concentration during 
pregnancy.
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Fig. 4. Box and whisker plots of serum osmolality, urine volume, urine osmolality, solute excretion, free-water clearance (FWC) and 
electrolyte-free water clearance (EFWC) during pregnancy and puerperium. Plot symbols are explained in Fig. 1.
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Urinary excretion of electrolytes
The cumulative requirements during preg­
nancy of sodium and of potassium were estimated 
to be 987 and 320 mEq, respectively [32]. This 
implies a daily retention of about 3 -4  mmol of 
sodium and of .1-2 mmol of potassium. The uri­
nary excretion of sodium tended to increase dur­
ing pregnancy in our study. Potassium excretion 
during pregnancy was moderately enhanced. 
Brown et al. [33] found no significant change in 
pregnancy compared to post partum values. One 
would expect that the high mineralocorticoid con­
centrations during normal pregnancy would cause 
considerable urinary potassium loss, but high pro­
gesterone levels seem to attenuate the kaliuretic 
effects of these mineralocorticoids [34].
Creatinine, urea and uric acid
The changes in creatinine clearance and the 
serum concentrations of creatinine, urea and uric 
acid confirm the results of other studies [35-40]. 
The uric acid clearance decreases in late gesta­
tion without a decrease in inulin clearance. The 
renal handling of uric acid appears to change in 
the course of pregnancy, resulting in increased 
tubular re-absorption in late gestation [39].
Urine volume, osmolality o f serum and urine,
EFWC and FWC
Uvoi was 25% higher during pregnancy than at 
6P, EFWC tended to be higher, Sosmo, and Uosmol 
decreased considerably, whereas FWC remained 
unaltered. The amount of water excreted in the 
urine consists of two fractions; a fraction neces­
sary to excrete the solutes in a solution that is 
Iso-osmotic to plasma and a fraction of free-water 
(FWC). If the urine is hyperosmotic to plasma, 
then the FWC is negative. Uvo] normally mirrors 
the oral fluid intake, implying that fluid intake is 
increased during pregnancy. Our data suggest 
that the increment in the solutes that have to be 
excreted explains the major part of the enhanced 
urine volume. Although the excretion of solutes 
was not significantly changed during pregnancy, 
the median values were at most of the time-points 
about 100 mosmol/24 h higher than those in the 
non-pregnant situation. If 100 mosmol have to be
excreted in an iso-osmotic solution to plasma, i.e. 
about 275 mosmol/kg, then 0.364 kg of water is 
required. This corresponds well with the observed 
increment in urine volume in pregnancy. In­
creased urine volumes in pregnancy have been 
reported previously [41], while others found no 
significant differences [42], Of interest in the reg­
ulation of UvoI is the osmotic threshold for argi- 
nine-vasopressin (AVP) release. The osmotic 
threshold for thirst is about 5 mosmol/kg higher 
than that for AVP release. Both thresholds de­
crease by about 10 mosmol/kg during human 
pregnancy [43]. The decrease of the two osmotic 
thresholds and the resulting decrease of the Posmoi 
has been attributed to human chorionic go­
nadotrophin (hCG), because treatment with hCG 
in non-pregnant women also results in a decline 
of the two osmotic thresholds and Posmoi with 
approximately 5 mosmol/kg [44]. Obviously some 
caution must be taken while interpreting the re­
sults on urinary parameters, due to possible in­
complete collection of 24-h urine samples. How­
ever, if present, these inadequacies appear to be 
comparable during and after pregnancy as mean 
urinary creatinine excretions were in the same 
range in all periods studied. This means that 
trends are still detectable.
Serum concentrations o f bilirubin, AS AT, A LA 1] 
y-GT, LDH and alkaline phosphatase
The increase in total, heat-stable and heat-un- 
stable alkaline phosphatase is well known. Both 
placental alkaline phosphatase (heat-stable) and 
bone alkaline phosphatase (heat-unstable) in­
crease whereas liver alkaline phosphatase (heat- 
unstable) remains unaltered. Six weeks after de­
livery, placental alkaline phosphatase returns be­
low the detection limit, but the bone isoenzyme is 
still above the baseline value [45]. The LDH 
concentration in serum either remains unaltered 
or increases only to a small extent during normal 
pregnancy [46]. The observed enhancement of 
serum LDH at 1 week after delivery could origi­
nate from the uterine muscles, due to the involu­
tion of the uterus, and from damaged erythro­
cytes involved in the haemostatic process in the 
placental bed.
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5. Conclusions
The reference values of most investigated rou­
tine laboratory parameters change during preg­
nancy and the puerperium. Physicians treating 
pregnant women must be aware of the physiologi­
cal changes that occur during pregnancy to avoid 
misinterpretation of results of laboratory investi­
gation, leading to erroneous diagnoses and hence 
to incorrect treatment or unjustified abstinence 
from treatment.
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